Rheumatoid Arthritis Active Not Recruiting Phase 4 Trials for Adalimumab (DB00051)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02353780Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or AbataceptBasic Science
NCT02092467Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisTreatment
NCT02557100Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid ArthritisBasic Science
NCT02056184Targeted Ultrasound in Rheumatoid ArthritisTreatment
NCT01893996Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint DiseasePrevention